Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Tipping DR et al. | 1999 | invertebrate, <i>Drosophila melanogaster</i> | magnetic field, 50/60 Hz | 8 µT |
Loberg LI et al. | 1999 | intact cell/cell culture, HBL-100 (human breast cancer cell line) and HME (human non-transformed mammary epithelial cells) | magnetic field, 50/60 Hz | 1 mT |
Campbell-Beachler M et al. | 1998 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz, co-exposure | 12.5–100 µT |
Lin H et al. | 1998 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz | 8 µT |
Lin H et al. | 1998 | intact cell/cell culture, HL-60 (human promyelocytic leukemia cells), MCF-7, T-47D, and HTB-124 cell lines (human breast cancer cell lines) | magnetic field, 50/60 Hz | 8 µT |
Balcer-Kubiczek EK et al. | 1998 | DNA/RNA, intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz | 2 mT |
Dibirdik I et al. | 1998 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) (wild-type, LYN-deficient, SYK-deficient, PLC-gamma2-deficient clones) | magnetic field, 50/60 Hz | 100 µT |
Miyakoshi J et al. | 1998 | intact cell/cell culture, CHO-K1 (Chinese hamster ovary K1) cells | magnetic field, 50/60 Hz, co-exposure | 5–400 mT |
Jahreis GP et al. | 1998 | intact cell/cell culture, CEM-CM3 (human acute lymphoblastic leukemia) cells | magnetic field, 50/60 Hz | 0.1 mT |
Kristupaitis D et al. | 1998 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) (wild-type, LYN-deficient, SYK-deficient, PLC-gamma2-deficient clones) | magnetic field, 50/60 Hz, co-exposure | 0.1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.